4//SEC Filing
Barlow Jane F 4
Accession 0001179110-20-010058
CIK 0001235010other
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 5:08 PM ET
Size
7.9 KB
Accession
0001179110-20-010058
Insider Transaction Report
Form 4
Barlow Jane F
Director
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2020-10-01−50,000→ 0 totalExercise: $15.71Exp: 2029-12-11→ Common Stock (50,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2020-10-01−25,000→ 0 totalExercise: $38.09Exp: 2030-06-23→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]Reflects disposition of options to acquire shares of Issuer common stock (each, an "Issuer Option") in accordance with that certain Agreement and Plan of Merger, dated as of August 19, 2020, by and among Johnson & Johnson, Vigor Sub, Inc. and the Issuer, pursuant to which, effective immediately prior to the effective time of the merger contemplated thereby (the "Effective Time"), each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which $52.50 exceeds the per share exercise price of such Issuer Option.
Documents
Issuer
MOMENTA PHARMACEUTICALS INC
CIK 0001235010
Entity typeother
Related Parties
1- filerCIK 0001736026
Filing Metadata
- Form type
- 4
- Filed
- Sep 30, 8:00 PM ET
- Accepted
- Oct 1, 5:08 PM ET
- Size
- 7.9 KB